Bipolar Disorder Clinical Trial
— ODROfficial title:
A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses
NCT number | NCT04612777 |
Other study ID # | 7419 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 15, 2014 |
Est. completion date | May 31, 2020 |
Verified date | October 2020 |
Source | New York State Psychiatric Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Insufficient community-based support after inpatient discharge for persons with serious mental illnesses (SMI) may lead to re-hospitalization, excessive criminal justice involvement, homelessness, and an inability to embrace recovery. In fact, many of these especially vulnerable persons find themselves in a cycle of repeated hospital stays, arrests, and even homelessness, with little support for real recovery. Public mental health systems are struggling to address these problems. Evidence-based, comparatively inexpensive, time-limited community support models are needed to reduce institutional recidivism and facilitate recovery. The Georgia chapter of the National Alliance on Mental Illness (NAMI-GA) developed Opening Doors to Recovery (ODR), and we have collected extensive preliminary data on it. ODR is now being tested in a randomized controlled trial (RCT) taking place in southeast Georgia where ODR was first developed. The primary goals of ODR are to prevent institutional recidivism (i.e., going back into the hospital) and to promote recovery among persons with SMI like schizophrenia and bipolar disorder. The ODR intervention is comprised of several components that work together to address barriers to successful integration into the community among individuals with SMI and repeated inpatient hospitalizations. A team of 3 specially trained "Community Navigation Specialists" (CNSs, also called Navigators) provides intensive, mobile, community support to persons with SMI with a defined history of inpatient recidivism (i.e., repeated hospital stays). We are carrying out a fully powered trial of ODR in a 7-county catchment area in southeast Georgia, which is an ideal real-world location to carry out the study. During the 5-year study period, we will randomize 240 persons with SMI and a history of ≥2 inpatient stays in the past 12 months to ODR (n=120, followed for 12 months, with a maximum CNS caseload of 40) versus community care in traditional intensive case management or case management (ICM/CM, n=120). Assessments are conducted at baseline (just before hospital discharge), and at 4, 8, 12, and 18 months.
Status | Completed |
Enrollment | 240 |
Est. completion date | May 31, 2020 |
Est. primary completion date | December 5, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Able to speak/read English - Clinical diagnosis of one of the following: psychotic disorder, bipolar disorder, or major depressive disorder - Capacity to give informed consent - Being discharged to one of seven counties served by Gateway Behavioral Health Services - Being hospitalized on an adult, non-forensics unit at Georgia Regional Hospital at Savannah, the Gateway-Brunswick CSU, or the Savannah CSU (located at Coastal Harbor) for =2 nights - At least one additional prior hospitalization or CSU stay of =2 nights within the past 12 months (our definition of "institutional recidivism") - Inability to complete activities of daily living in at least two of the following areas despite support from caregiver or behavioral health staff (this is a criterion previously established for receiving ICM services): 1. navigate and self-manage necessary services, 2. maintain personal hygiene, meet nutritional needs, 3. care for personal business affairs, obtain or maintain medical, legal, and housing services, 4. recognize and avoid common dangers or hazards to self and possessions, 5. perform daily living tasks, 6. obtain or maintain employment at a self-sustaining level or consistently perform homemaker roles (meal preparation, washing clothes, budgeting, or childcare tasks and responsibilities), 7. maintain safe living situation (evicted from housing/recent loss of housing/imminent risk of loss of housing) - Requires assistance with one or more of the following as an indicator of demonstrated ownership and engagement with his/her own illness self-management (this also is a criterion previously established for receiving ICM services): a. Taking prescribed medications b. Following a crisis plan c. Maintaining community integration d. Keeping appointments with needed services which have resulted in the exhibition of specific behaviors that have led to two or more of the following within the past 18 months (hospitalization, incarcerations, homelessness, or use of other crisis services) Exclusion Criteria: - Known or suspected intellectual disability, mental retardation, or dementia - Known or suspected autism-spectrum disorder, organic mental disorder, and/or traumatic brain injury - Significant medical condition compromising ability to participate (e.g., short of breath, in pain) - Having taken part in the initial ODR study or being enrolled in any other study. - Being referred to ACT - Not having the ability to provide informed consent for the study |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
New York State Psychiatric Institute | Emory University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of inpatient psychiatric stays and days for intervention and control participants | Data on inpatient psychiatric stays will be collected from the Georgia Department of Behavioral Health and Developmental Disabilities, Gateway Behavioral Health Services Crisis Stabilization Unit in Brunswick, Georgia, and Coastal Harbor Crisis Stabilization Unit in Savannah, Georgia.
Hypothesis A1: ODR participants will have fewer total days in inpatient psychiatric settings during a 12-month period compared to participants in ICM/CM. Hypothesis A2: Effects on hospital recidivism will persist at 18 months (6 months after being transitioned out of ODR). |
18 months of study enrollment | |
Primary | Number of arrests for intervention and control participants | Participants' Record of Arrest and Prosecution (RAP) sheets will be collected from the Georgia Bureau of Investigation, and data on each participant's arrests during the study period will be extracted.
Hypothesis B1: ODR participants will have fewer arrests during a 12-month period compared to participants in ICM/CM. Hypothesis B2: Effects on arrests will persist at 18 months. |
18 months of study enrollment | |
Secondary | Scores on the Housing Instability Index (HII) | The Housing Instability Index will be administered orally to all study participants during the routine follow-up assessments at 4-months, 8-months, 12-months, and 18-months.
Hypothesis C1a: ODR participants will have lesser housing instability during a 12-month period compared to participants in ICM/CM. Hypothesis C2a: Effects on housing instability will persist at 18 months. |
18 months of study enrollment | |
Secondary | Scores on the Housing Satisfaction Scale (HSS) | The Housing Satisfaction Scale (HSS) will be administered orally to all study participants during the routine follow-up assessments at 4-months, 8-months, 12-months, and 18-months.
Hypothesis C1b: ODR participants will have greater housing satisfaction during a 12-month period compared to participants in ICM/CM. Hypothesis C2b: Effects on housing satisfaction will persist at 18 months. |
18 months of study enrollment | |
Secondary | Scores on the Multnomah Community Adjustment Scale (MCAS) | At each routine follow-up assessments at 4-months, 8-months, 12-months, and 18-months, participants will respond to the Multnomah Community Adjustment Scale.
Hypothesis D1a: ODR participants will have greater recovery, based on the scale of community adjustment, during a 12-month period compared to participants in ICM/CM. Hypothesis D2a: Effects on recovery will persist at 18 months. |
18 months of study enrollment | |
Secondary | Scores on the Maryland Assessment of Recovery in People with Serious Mental Illness (MARS) | At each routine follow-up assessments at 4-months, 8-months, 12-months, and 18-months, participants will respond to the Maryland Assessment of Recovery in People with Serious Mental Illness.
Hypothesis D1b: ODR participants will have greater recovery, based on the MARS scale, during a 12-month period compared to participants in ICM/CM. Hypothesis D2b: Effects on recovery will persist at 18 months. |
18 months of study enrollment | |
Secondary | Scores on the Herth Hope Scale (HHS) | At each routine follow-up assessments at 4-months, 8-months, 12-months, and 18-months, participants will respond to the Herth Hope Scale (HHS).
Hypothesis D1c: ODR participants will have greater recovery, based on the HHS, during a 12-month period compared to participants in ICM/CM. Hypothesis D2c: Effects on recovery will persist at 18 months. |
18 months of study enrollment | |
Secondary | Scores on the Empowerment Scale | At each routine follow-up assessments at 4-months, 8-months, 12-months, and 18-months, participants will respond to the Empowerment Scale.
Hypothesis D1d: ODR participants will have greater recovery, based on the Empowerment Scale, during a 12-month period compared to participants in ICM/CM. Hypothesis D2d: Effects on recovery will persist at 18 months. |
18 months of study enrollment | |
Secondary | Scores on the Community Navigation Abilities Scale (CNAS) | At each routine follow-up assessments at 4-months, 8-months, 12-months, and 18-months, participants will respond to the Community Navigation Abilities Scale (CNAS).
Hypothesis D1e: ODR participants will have greater recovery, based on the CNAS, during a 12-month period compared to participants in ICM/CM. Hypothesis D2e: Effects on recovery will persist at 18 months. |
18 months of study enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 |